Relationship between Cystatin C, Retinol-binding Protein 4 and Framingham Risk Score in Healthy Postmenopausal Women

Aleksandra Klisic1, Jelena Kotur-Stevuljevic2, Nebojsa Kavaric1

  • 1Primary Health Care Center, Podgorica, Montenegro.

Insights

High levels of cystatin C and retinol-binding protein 4 (RBP4) are linked to increased cardiovascular risk in postmenopausal women. These proteins, along with BMI and triglycerides, can predict cardiovascular risk effectively.

Area of Science:

  • Biochemistry
  • Cardiology
  • Endocrinology

Background:

  • Investigating novel biomarkers for cardiovascular disease (CVD) risk is crucial, especially in postmenopausal women.
  • Cystatin C and retinol-binding protein 4 (RBP4) are emerging markers with potential implications for CVD.
  • The Framingham Risk Score (FRS) is a traditional tool for assessing cardiovascular risk.

Purpose of the Study:

  • To examine the association between elevated cystatin C, RBP4 levels, and cardiovascular risk score (FRS) in postmenopausal women.
  • To identify independent predictors of cardiovascular risk in this population.

Main Methods:

  • A cohort of 129 healthy postmenopausal women was studied.
  • Serum levels of cystatin C, RBP4, glucose, lipids, creatinine, uric acid, and hsCRP were measured.
  • Multiple linear regression and Receiver Operating Characteristic (ROC) curve analyses were employed to assess FRS and its predictors.

Main Results:

  • Significantly higher cystatin C and RBP4 levels were observed in women with higher FRS (≥10%).
  • Multiple linear regression identified body mass index (BMI), triglycerides (TG), RBP4, and cystatin C as significant independent predictors of FRS (R2-adjusted = 0.347).
  • A combined model using these four parameters demonstrated excellent discriminatory capability for cardiovascular risk (AUC = 0.820).

Conclusions:

  • Elevated cystatin C and RBP4 levels are associated with increased cardiovascular risk in postmenopausal women.
  • These proteins may serve as valuable additions to traditional cardiovascular risk assessment tools.
  • The findings highlight the potential of cystatin C and RBP4 in predicting cardiovascular risk burden.
Abstract